These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37993175)

  • 21. Profiling Genome-Wide DNA Methylation in Children with Autism Spectrum Disorder and in Children with Fragile X Syndrome.
    Jasoliya M; Gu J; AlOlaby RR; Durbin-Johnson B; Chedin F; Tassone F
    Genes (Basel); 2022 Oct; 13(10):. PubMed ID: 36292679
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Fyke W; Velinov M
    Genes (Basel); 2021 Aug; 12(8):. PubMed ID: 34440392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hispano-American Brain Bank on Neurodevelopmental Disorders: An initiative to promote brain banking, research, education, and outreach in the field of neurodevelopmental disorders.
    Dufour BD; Albores-Gallo L; Luna-Muñoz J; Hagerman R; Miquelajauregui A; Buriticá E; Saldarriaga W; Pacheco-Herrero M; Yris Silvestre-Sosa A; Mazefsky C; Gastgeb H; Kofler J; Casanova M; Hof PR; London E; Hagerman P; Martínez-Cerdeño V
    Brain Pathol; 2022 Mar; 32(2):e13019. PubMed ID: 34515386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mass spectrometry for the study of autism and neurodevelopmental disorders.
    Ngounou Wetie AG; Dekroon RM; Mocanu M; Ryan JP; Darie CC; Woods AG
    Adv Exp Med Biol; 2014; 806():525-44. PubMed ID: 24952201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteome profiling of the prefrontal cortex of Fmr1 knockout mouse reveals enhancement of complement and coagulation cascades.
    Gao MM; Shi H; Yan HJ; Long YS
    J Proteomics; 2023 Mar; 274():104822. PubMed ID: 36646274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autism Spectrum Disorder Symptoms in Infants with Fragile X Syndrome: A Prospective Case Series.
    Hogan AL; Caravella KE; Ezell J; Rague L; Hills K; Roberts JE
    J Autism Dev Disord; 2017 Jun; 47(6):1628-1644. PubMed ID: 28281129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deficits in olfactory system neurogenesis in neurodevelopmental disorders.
    Sweat SC; Cheetham CEJ
    Genesis; 2024 Apr; 62(2):e23590. PubMed ID: 38490949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dysregulation of Neurite Outgrowth and Cell Migration in Autism and Other Neurodevelopmental Disorders.
    Prem S; Millonig JH; DiCicco-Bloom E
    Adv Neurobiol; 2020; 25():109-153. PubMed ID: 32578146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preferences for the research use of electronic health records among young adults with fragile X syndrome or autism spectrum disorder.
    Wagner L; Frisch M; Turner-Brown L; Andrews S; Edwards A; Moultrie R; Alvarez Rivas A; Wheeler A; Raspa M
    Disabil Health J; 2020 Oct; 13(4):100927. PubMed ID: 32360031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autism spectrum disorder in the fragile X premutation state: possible mechanisms and implications.
    Aishworiya R; Protic D; Hagerman R
    J Neurol; 2022 Sep; 269(9):4676-4683. PubMed ID: 35723724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Language Skills of Males with Fragile X Syndrome or Nonsyndromic Autism Spectrum Disorder.
    Thurman AJ; McDuffie A; Hagerman RJ; Josol CK; Abbeduto L
    J Autism Dev Disord; 2017 Mar; 47(3):728-743. PubMed ID: 28074353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gaze avoidance and perseverative language in fragile X syndrome and autism spectrum disorder: brief report.
    Friedman L; Sterling A; Barton-Hulsey A
    Dev Neurorehabil; 2018 Feb; 21(2):137-140. PubMed ID: 29333915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autism and fragile X syndrome.
    Yu TW; Berry-Kravis E
    Semin Neurol; 2014 Jul; 34(3):258-65. PubMed ID: 25192504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deciphering the roles of glycogen synthase kinase 3 (GSK3) in the treatment of autism spectrum disorder and related syndromes.
    Rizk M; Saker Z; Harati H; Fares Y; Bahmad HF; Nabha S
    Mol Biol Rep; 2021 Mar; 48(3):2669-2686. PubMed ID: 33650079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelets as a surrogate disease model of neurodevelopmental disorders: Insights from Fragile X Syndrome.
    Pellerin D; Lortie A; Corbin F
    Platelets; 2018 Mar; 29(2):113-124. PubMed ID: 28660769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intellectual functioning and behavioural features associated with mosaicism in fragile X syndrome.
    Baker EK; Arpone M; Vera SA; Bretherton L; Ure A; Kraan CM; Bui M; Ling L; Francis D; Hunter MF; Elliott J; Rogers C; Field MJ; Cohen J; Maria LS; Faundes V; Curotto B; Morales P; Trigo C; Salas I; Alliende AM; Amor DJ; Godler DE
    J Neurodev Disord; 2019 Dec; 11(1):41. PubMed ID: 31878865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Finding novel distinctions between the sAPPα-mediated anabolic biochemical pathways in Autism Spectrum Disorder and Fragile X Syndrome plasma and brain tissue.
    Ray B; Sokol DK; Maloney B; Lahiri DK
    Sci Rep; 2016 May; 6():26052. PubMed ID: 27212113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular analyses of neurogenic defects in a human pluripotent stem cell model of fragile X syndrome.
    Boland MJ; Nazor KL; Tran HT; Szücs A; Lynch CL; Paredes R; Tassone F; Sanna PP; Hagerman RJ; Loring JF
    Brain; 2017 Mar; 140(3):582-598. PubMed ID: 28137726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fragile X Syndrome: Lessons Learned and What New Treatment Avenues Are on the Horizon.
    Hagerman RJ; Hagerman PJ
    Annu Rev Pharmacol Toxicol; 2022 Jan; 62():365-381. PubMed ID: 34499526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disease-Targeted Treatment Translation in Fragile X Syndrome as a Model for Neurodevelopmental Disorders.
    Berry-Kravis E
    J Child Neurol; 2022 Oct; 37(10-11):797-812. PubMed ID: 35791522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.